Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency.
Philippa B Mills, Emma J Footitt, Serkan Ceyhan, Paula J Waters, Cornelis Jakobs, Peter T Clayton, Eduard A Struys
文献索引:J. Inherit. Metab. Dis. 35(6) , 1031-6, (2012)
全文:HTML全文
摘要
Analysis of α-aminoadipic semialdehyde is an important tool in the diagnosis of antiquitin deficiency (pyridoxine-dependent epilepsy). However continuing use of this test has revealed that elevated urinary excretion of α-aminoadipic semialdehyde is not only found in patients with pyridoxine-dependent epilepsy but is also seen in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency. This should be taken into account when interpreting the laboratory data. Sulphite was shown to inhibit α-aminoadipic semialdehyde dehydrogenase in vitro.
相关化合物
相关文献:
2015-07-01
[Food Chem. 178 , 221-8, (2015)]
2009-02-12
[Nature 457(7231) , 910-4, (2009)]
2015-03-25
[J. Pharm. Biomed. Anal. 107 , 456-63, (2015)]
2011-06-01
[Kidney Int. 79(11) , 1244-53, (2011)]
2014-06-16
[Eur. J. Pharm. Sci. 57 , 25-33, (2014)]